ITGA5与头部和部状细胞癌的预后标志物和免疫抑制有关

Jianmin Liu1, Yongkuan Wang2, Xi Chen2

  • 1Department of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu City, Sichuan Province, China.

Diagnostic pathology
|October 7, 2024
PubMed
概括

综合素α5 (ITGA5) 可能作为头部和部状细胞癌 (HNSCC) 的预后生物标志物. 它的表达与瘤转移,免疫抑制和抵抗PI3K-AKT向化疗相关.